Compare MKSI & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MKSI | HOLX |
|---|---|---|
| Founded | 1961 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 16.9B |
| IPO Year | 1997 | 1995 |
| Metric | MKSI | HOLX |
|---|---|---|
| Price | $280.94 | $76.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 13 |
| Target Price | ★ $255.62 | $77.89 |
| AVG Volume (30 Days) | 885.0K | ★ 11.6M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | ★ 55.52 | N/A |
| EPS | ★ 4.37 | 0.79 |
| Revenue | $3,931,000,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $15.87 | $4.74 |
| Revenue Next Year | $10.78 | $5.03 |
| P/E Ratio | ★ $63.71 | $96.23 |
| Revenue Growth | ★ 9.62 | 1.74 |
| 52 Week Low | $61.00 | $51.90 |
| 52 Week High | $281.77 | $76.07 |
| Indicator | MKSI | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 68.66 | 69.09 |
| Support Level | $208.96 | $75.10 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 9.95 | 0.19 |
| MACD | 3.59 | 0.03 |
| Stochastic Oscillator | 91.89 | 95.19 |
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.